New COVID research from Dr. Samira Musah (Pratt/SoM) Is Highlighted in Two Forbes Magazine Articles!

While cells in the respiratory system are the initial target of SARS-CoV-2, there is mounting evidence that COVID-19 is a multi-organ disease. The Musah lab made new discoveries on how the virus is able to bind and invade kidney cells.

Forbes 1: A Dynamic Duo: How ACE-2 And CD147 Mediate Covid-19 Infection In The Kidneys

Forbes 2: Targets for Infection: How SARS-CoV-2 Damages the Kidneys

Article: SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes

Titilola D. Kalejaiye, Rohan Bhattacharya, Morgan A. Burt, Tatianna Travieso, Arinze E. Okafor, Xingrui Mou, Maria Blasi and Samira Musah

Front. Cell Dev. Biol., 20 April 2022 | https://doi.org/10.3389/fcell.2022.855340